Table 2

Summary and group comparisons of outcomes

MeasureOutcomeADHDTDCt (pFDR)
SpectroscopySMA GABA, i.u.2.72 ± 0.35 (n = 20)2.55 ± 0.24 (n = 21)1.8 (p = 0.06)
SMA Glx, i.u.11.97 ± 1.04 (n = 26)11.90 ± 1.15 (n = 25)0.2 (p = 0.56)
M1 GABA, i.u.2.84 ± 0.32 (n = 19)2.83 ± 0.41 (n = 23)0.1 (p = 0.56)
M1 Glx, i.u.8.64 ± 1.00 (n = 24)9.35 ± 1.29 (n = 23)−2.0 (p = 0.044)*
Motor mappingRMT, % stimulator output66.7 ± 16.0 (n = 25)78.3 ± 12.6 (n = 17)−2.4 (p = 0.029)*
Area, mm2848 ± 308 (n = 23)1078 ± 364 (n = 14)−2.1 (p = 0.044)*
Hotspot density, log0.14 ± 0.08 (n = 23)0.07 ± 0.03 (n = 14)3.2 (p = 0.008)*
  • ADHD = attention-deficit/hyperactivity disorder; FDR = false discovery rate; GABA = γ-aminobutyric acid; Glx = glutamate + glutamine; i.u. = institutional units; M1 = primary motor area of dominant hand; RMT = resting motor threshold; SMA = supplementary motor area; TDC = typically developing children.

  • * p < 0.05 difference between groups.